Fertility Preservation and Reproductive Care in Transgender and Gender Diverse Patient Population Perceptions and Experiences

Overview

About this study

The purpose of this study is to understand patient perceptions of barriers in receiving care pertaining to reproductive health and family planning for transgender and gender diverse (TGD) patients. Additionally, to examine patient attitudes towards fertility preservation and reproductive health topics following the initiation of gender affirming care, and to examine how experiences of gender affirmation and fertility preservation differ based on location, socioeconomic status, age, and type of gender-affirming intervention.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Transgender and gender diverse (TGD) identifying patients.
  • Patients ≥ 18 years old.
  • Patients who are seeking or have sought gender-affirming care or fertility preservation.
  • Willingness to provide informed consent and allow recording of the interview.
  • Speaks and understand English language proficiently.

Exclusion Criteria: 

  • Patients who are not transgender or gender diverse or have not received gender-affirming care or counseling.
  • Participants under 18 years old.

Eligibility last updated 8/3/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Zaraq Khan, M.B.B.S.

Open for enrollment

Contact information:

Jensen Reckhow M.D., M.P.H.

Reckhow.Jensen@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Jacob Eleazer, Ph.D.

Open for enrollment

Contact information:

Karen DSouza

(904) 953-0439

DSouza.Karen@mayo.edu

More information

Publications

Publications are currently not available